SCHEMBL24465197

SCHEMBL24465197

CCCCCCCC/C=C/CCCCCC(=O)OC1CCCn2c1nc(C)c(CCN1CCC(c3noc4cc(F)ccc34)CC1)c2=O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 12/20 0.66
HTR2A P28223 12/20 0.66
HTR7 P34969 5/20 0.66
KCNH2 Q12809 5/20 0.66
ADRA2A P08913 2/20 0.66
ADRA2B P18089 2/20 0.66
ADRA2C P18825 2/20 0.66
DRD1 P21728 2/20 0.66
DRD4 P21917 2/20 0.66
DRD5 P21918 2/20 0.66
HTR1D P28221 2/20 0.66
HTR1B P28222 2/20 0.66
HTR2C P28335 2/20 0.66
ADRA1A P35348 2/20 0.66
HRH1 P35367 2/20 0.66
DRD3 P35462 2/20 0.66
SCN5A Q14524 2/20 0.66
KCND3 Q9UK17 1/20 0.66
SLC6A4 P31645 2/20 0.58
ACHE P22303 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14378106 1.00 DRD2 (0.66) DRD2HTR2AHTR7KCNH2ADRA2A
SCHEMBL4263975 0.96 DRD2 (0.71) DRD2HTR2AHTR7KCNH2ADRA2A
SCHEMBL4273254 0.96 DRD2 (0.71) DRD2HTR2AHTR7KCNH2ADRA2A
Paliperidone Palmitate SCHEMBL1871384 0.96 DRD2 (0.71) DRD2HTR2AHTR7KCNH2ADRA2A
SCHEMBL24018542 0.96 DRD2 (0.71) DRD2HTR2AHTR7KCNH2ADRA2A
Paliperidone Palmitate SCHEMBL12415674 0.96 DRD2 (0.71) DRD2HTR2AHTR7KCNH2ADRA2A
Paliperidone Palmitate SCHEMBL18131955 0.96 DRD2 (0.71) DRD2HTR2AHTR7KCNH2ADRA2A
SCHEMBL7343354 0.96 DRD2 (0.71) DRD2HTR2AHTR7KCNH2ADRA2A
Hydrochloric Acid SCHEMBL9196896 0.96 DRD2 (0.70) DRD2HTR2AHTR7KCNH2ADRA2A
SCHEMBL6881948 0.91 DRD2 (0.71) DRD2HTR2AHTR7KCNH2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4005555-A1 METHODS FOR ENSURING RESUSPENSION OF PALIPERIDONE PALMITATE FORMULATIONS Janssen Pharmaceutica NV (BE) 2022-06-01 EP disclosed